CIAM
VKTX icon

Caitong International Asset Management’s Viking Therapeutics VKTX Stock Holding History

Caitong International Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68K Sell
43
-6,249
-99% -$202K ﹤0.01% 1430
2026
Q1 		$205K Buy
+6,292
New +$202K 0.04% 376
2025
Q3 		– Sell
-4,098
Closed -$109K – 2554
2025
Q2 		$109K Buy
4,098
+3,966
+3,005% +$104K 0.08% 144
2025
Q1 		$3.19K Sell
132
-8,087
-98% -$256K ﹤0.01% 1163
2024
Q4 		$331K Buy
+8,219
New +$469K 0.32% 33

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Caitong International Asset Management's VKTX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Viking Therapeutics (VKTX) stake by 99% in Q2 2026, selling an estimated $202K and leaving 43 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Caitong International Asset Management first reported a position in VKTX in Q4 2024 and has held it in 5 quarters since. The position peaked at $331K in Q4 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Caitong International Asset Management held 43 shares of Viking Therapeutics worth $1.68K as of Q2 2026.
  • Caitong International Asset Management sold 6,249 Viking Therapeutics shares in Q2 2026, an estimated $202K.
  • Viking Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1430 holding.
  • Caitong International Asset Management first reported a position in Viking Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Viking Therapeutics position peaked at $331K in Q4 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.